NCT02758834 Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition Status COMPLETED Phase N/A
NCT02686762 Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis Status COMPLETED Phase PHASE2
NCT02613403 Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) Status TERMINATED Phase PHASE2
NCT02542020 Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis Status UNKNOWN Phase N/A
NCT02533193 Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy Status COMPLETED Phase NA
NCT02489045 Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension Status COMPLETED Phase PHASE4
NCT02337673 Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography Status COMPLETED Phase N/A
NCT02279524 A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH Status COMPLETED Phase PHASE2
NCT02208804 Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization Status UNKNOWN Phase PHASE2/PHASE3
NCT02171832 Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT02121860 PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02073435 A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation Status COMPLETED Phase N/A
NCT01870388 A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease Status COMPLETED Phase PHASE1
NCT01760148 Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2) Status UNKNOWN Phase N/A
NCT01556815 Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2